# The Effect of Opioids on P2Y12 Receptor Inhibition in Patients With ST-Elevation Myocardial Infarction Who Are Pre-treated With Crushed Ticagrelor

> **NCT03400267** · PHASE4 · COMPLETED · sponsor: **A.H. Tavenier** · enrollment: 200 (actual)

## Conditions studied

- STEMI
- STEMI - ST Elevation Myocardial Infarction

## Interventions

- **DRUG:** Paracetamol
- **DRUG:** Fentanyl

## Key facts

- **NCT ID:** NCT03400267
- **Lead sponsor:** A.H. Tavenier
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-16
- **Primary completion:** 2019-10-22
- **Final completion:** 2019-11-22
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2020-02-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03400267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03400267, "The Effect of Opioids on P2Y12 Receptor Inhibition in Patients With ST-Elevation Myocardial Infarction Who Are Pre-treated With Crushed Ticagrelor". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03400267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*